Ledger.Open graph →
SEC Form D · filed January 20, 2017

RHYTHM PHARMACEUTICALS, INC

Offering
$40.9M
Sold
$20.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Edward T. Mathers · Timonium, MDDirectorDavid P. Meeker, M.D · Cambridge, MADirectorDavid J. Mcgirr · Greenwich, CTDirectorJonathan T. Silverstein · New York, NYDirectorChristophe Jean · Slough, United KingdomDirectorNeil Exter · Boston, MADirectorTodd T. Foley · Boston, MADirectorBart T. Henderson · Boston, MAExec · PromoterKeith Gottesdiener · Boston, MAExec · Director · PromoterArvind Rajan · San Francisco, CADirectorDan Simons · Kensington, MDDirectorWilliam Weatherford · Tampa, FLDirectorEric J. Klein · Menlo Park, CADirectorJoel D. Brinton · Menlo Park, CADirectorBabak N. Poushanchi · San Francisco, CADirectorSamuel Weatherford · Tampa, FLDirectorMichael Lavitola · Chicago, ILDirectorPaul A. Hughson · IRVING, TXDirectorMark Butters · Coconut Creek, FLDirectorTravis Mccourt · NEW YORK, NYDirectorRichard Rosenfield · Highland Park, ILDirectorDonald Devivo · New York, NYDirectorTriple Net Service Company, LLC · Northbrook, ILDirectorBart T. Henderson · Boston, MAExec · PromoterKeith Gottesdiener · Boston, MAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗